<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS: Metaplastic changes secondary to <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:mp ids='MP_0001845'>inflammation</z:mp> at the gastro-oesophageal junction and at the pyloric antrum are recognized as the <z:e sem="disease" ids="C0032927" disease_type="Neoplastic Process" abbrv="">premalignant conditions</z:e> of Barrett's oesophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> and intestinal-type gastric <z:mp ids='MP_0002038'>carcinoma</z:mp> (GC), respectively </plain></SENT>
<SENT sid="1" pm="."><plain>Heparanase (HPSE) and cyclooxygenase (COX)-2 have been proved to play critical roles in <z:mp ids='MP_0001845'>inflammation</z:mp> as well as in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>The aim was to examine the meaning of their expression in <z:mp ids='MP_0001845'>inflammation</z:mp>-related <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS AND RESULTS: First, expression of HPSE and COX-2 in 78 clinical tissues of <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> was examined by immunohistochemistry and in situ hybridization </plain></SENT>
<SENT sid="4" pm="."><plain>Their expression was increased during the <z:mpath ids='MPATH_160'>metaplasia</z:mpath>-<z:mpath ids='MPATH_589'>dysplasia</z:mpath> sequence with increased neovascularization </plain></SENT>
<SENT sid="5" pm="."><plain>Successively, their expression in Barrett's <z:mpath ids='MPATH_589'>dysplasia</z:mpath> was compared with that of GC (22 cases of diffuse-type and 10 of intestinal-type) </plain></SENT>
<SENT sid="6" pm="."><plain>Interestingly, the expression pattern in Barrett's <z:mpath ids='MPATH_589'>dysplasia</z:mpath> was similar to that in intestinal-type GC, which mainly arises from <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:mp ids='MP_0001845'>inflammation</z:mp> </plain></SENT>
<SENT sid="7" pm="."><plain>Furthermore, cultured cell lines isolated from differentiated GC tissues, which are often found to be of intestinal-type, revealed up-regulated <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression of HPSE and COX-2 </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: HPSE and COX-2 are preferentially up-regulated in <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> and intestinal-type GC </plain></SENT>
<SENT sid="9" pm="."><plain>These molecules may play an important role during the development of <z:mp ids='MP_0001845'>inflammation</z:mp>-related <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> of the upper gastrointestinal tract </plain></SENT>
</text></document>